Zealand Pharma Forecast, price target & analysts
Zealand Pharma Target price 2025 - Analyst rating & recommendation
Zealand Pharma Classifications & Recommendation:
Zealand Pharma Price Target
| Target Price | kr841.50 |
| Price | kr500.60 |
| Potential |
68.10%
register free of charge
|
| Number of Estimates | 19 |
|
19 Analysts have issued a price target Zealand Pharma 2026 .
The average Zealand Pharma target price is kr841.50.
This is
68.10%
register free of charge
kr1,176.00
134.92%
register free of charge
kr434.30
13.24%
register free of charge
|
|
| A rating was issued by 25 analysts: 22 Analysts recommend Zealand Pharma to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Zealand Pharma stock has an average upside potential 2026 of
68.10%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion kr | 0.06 | 9.57 |
| 81.71% | 15,164.00% | |
| EBITDA Margin | -1,983.12% | 75.68% |
| 1,175.58% | 103.82% | |
| Net Margin | -1,720.90% | 64.44% |
| 738.24% | 103.74% |
17 Analysts have issued a sales forecast Zealand Pharma 2025 . The average Zealand Pharma sales estimate is
This results in the following potential growth metrics:
13 Analysts have issued an Zealand Pharma EBITDA forecast 2025. The average Zealand Pharma EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
17 Zealand Pharma Analysts have issued a net profit forecast 2025. The average Zealand Pharma net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share kr | -16.24 | 87.62 |
| 30.55% | 639.53% | |
| P/E | 5.54 |
17 Analysts have issued a Zealand Pharma forecast for earnings per share. The average Zealand Pharma EPS is
This results in the following potential growth metrics and future valuations:
Current Zealand Pharma Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| WELLS FARGO SECURITIES, LLC |
Locked
➜
Locked
|
Locked | Sep 07 2025 |
| WILLIAM BLAIR & COMPANY |
Locked
➜
Locked
|
Locked | Aug 14 2025 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Aug 14 2025 |
| CANTOR FITZGERALD |
Locked
➜
Locked
|
Locked | Aug 14 2025 |
| BTIG |
Locked
➜
Locked
|
Locked | Aug 14 2025 |
| KBC SECURITIES |
Locked
➜
Locked
|
Locked | Aug 14 2025 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Jul 15 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
WELLS FARGO SECURITIES, LLC:
Locked
➜
Locked
|
Sep 07 2025 |
|
Locked
WILLIAM BLAIR & COMPANY:
Locked
➜
Locked
|
Aug 14 2025 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Aug 14 2025 |
|
Locked
CANTOR FITZGERALD:
Locked
➜
Locked
|
Aug 14 2025 |
|
Locked
BTIG:
Locked
➜
Locked
|
Aug 14 2025 |
|
Locked
KBC SECURITIES:
Locked
➜
Locked
|
Aug 14 2025 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Jul 15 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
